Literature DB >> 15613349

Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Yorgo Modis1, Steven Ogata, David Clements, Stephen C Harrison.   

Abstract

Dengue virus is an emerging global health threat. The major envelope glycoprotein, E, mediates viral attachment and entry by membrane fusion. Antibodies that bind but fail to neutralize noncognate serotypes enhance infection. We have determined the crystal structure of a soluble fragment of the envelope glycoprotein E from dengue virus type 3. The structure closely resembles those of E proteins from dengue type 2 and tick-borne encephalitis viruses. Serotype-specific neutralization escape mutants in dengue virus E proteins are all located on a surface of domain III, which has been implicated in receptor binding. While antibodies against epitopes in domain I are nonneutralizing in dengue virus, there are neutralizing antibodies that recognize serotype-conserved epitopes in domain II. The mechanism of neutralization for these antibodies is probably inhibition of membrane fusion. Our structure shows that neighboring glycans on the viral surface are spaced widely enough (at least 32 A) that they can interact with multiple carbohydrate recognition domains on oligomeric lectins such as DC-SIGN, ensuring maximum affinity for these putative receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613349      PMCID: PMC538574          DOI: 10.1128/JVI.79.2.1223-1231.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.

Authors:  Duane J Gubler
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

2.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

3.  Implementation of molecular replacement in AMoRe.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

4.  Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.

Authors:  H Feinberg; D A Mitchell; K Drickamer; W I Weis
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

5.  Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody.

Authors:  S M Lok; M L Ng; J Aaskov
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

6.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Authors:  Ananda Nisalak; Timothy P Endy; Suchitra Nimmannitya; Siripen Kalayanarooj; Usa Thisayakorn; Robert M Scott; Donald S Burke; Charles H Hoke; Bruce L Innis; David W Vaughn
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

7.  Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses.

Authors:  Erika Navarro-Sanchez; Ralf Altmeyer; Ali Amara; Olivier Schwartz; Franck Fieschi; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Philippe Desprès
Journal:  EMBO Rep       Date:  2003-07       Impact factor: 8.807

8.  A ligand-binding pocket in the dengue virus envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-20       Impact factor: 11.205

9.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

Authors:  Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Xiao-ning Xu; Sirijitt Vasanawathana; Nattaya Tangthawornchaikul; Aroonrung Chairunsri; Siraporn Sawasdivorn; Thaneeya Duangchinda; Tao Dong; Sarah Rowland-Jones; Pa-thai Yenchitsomanus; Andrew McMichael; Prida Malasit; Gavin Screaton
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

10.  DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.

Authors:  Boonrat Tassaneetrithep; Timothy H Burgess; Angela Granelli-Piperno; Christine Trumpfheller; Jennifer Finke; Wellington Sun; Michael A Eller; Kovit Pattanapanyasat; Suttipant Sarasombath; Deborah L Birx; Ralph M Steinman; Sarah Schlesinger; Mary A Marovich
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

View more
  191 in total

1.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

Review 2.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

3.  Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera.

Authors:  Wahala M P B Wahala; Claire Huang; Siritorn Butrapet; Laura J White; Aravinda M de Silva
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Site-directed antibodies against the stem region reveal low pH-induced conformational changes of the Semliki Forest virus fusion protein.

Authors:  Maofu Liao; Margaret Kielian
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

6.  In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein.

Authors:  Maofu Liao; Claudia Sánchez-San Martín; Aihua Zheng; Margaret Kielian
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

Review 7.  Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.

Authors:  Haibin Liu; Yi Liu; Shaobo Wang; Yanjun Zhang; Xiangyang Zu; Zheng Zhou; Bo Zhang; Gengfu Xiao
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.